for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bioventix PLC

BVXP.L

Latest Trade

3,130.00GBp

Change

-20.00(-0.63%)

Volume

4,030

Today's Range

3,130.00

 - 

3,130.00

52 Week Range

3,000.00

 - 

4,549.23

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
3,150.00
Open
3,150.00
Volume
4,030
3M AVG Volume
0.13
Today's High
3,130.00
Today's Low
3,130.00
52 Week High
4,549.23
52 Week Low
3,000.00
Shares Out (MIL)
5.21
Market Cap (MIL)
164.09
Forward P/E
24.74
Dividend (Yield %)
3.02

Next Event

Half Year 2022 Bioventix PLC Earnings Release

Latest Developments

More

Bioventix FY Profit Before Tax Up 18%

Bioventix Plc Says Bruce Hiscock To Join Board As CFO

Bioventix Reports 6% Rise In FY Revenue

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Bioventix PLC

Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics, such as in automated immunoassays used in blood testing. The Company offers a portfolio of antibodies to customers for both commercial use and research and development (R&D) purposes, for the diagnosis or monitoring of a range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. The Company also supplies antibody products and services to multinational clinical diagnostics companies. The Company sells its products through direct sales and through distributors.

Industry

Biotechnology & Drugs

Contact Info

7 Romans Business Park, East Street

GU9 7SX

United Kingdom

+44.1252.728001

http://www.bioventix.com/

Executive Leadership

Ian James Nicholson

Non-Executive Independent Chairman of the Board

Peter Harrison

Chief Executive Officer, Director

Bruce Edward Heath Hiscock

Chief Financial Officer, Director

Treena Turner

Non-Executive Director

Nick McCooke

Non-Executive Independent Director

Key Stats

Revenue (MM, GBP)

2019

0.0K

2020

0.0K

2021

0.0K

2022(E)

0.0K
EPS (GBp)

2019

112.120

2020

137.930

2021

127.940

2022(E)

127.300
Price To Earnings (TTM)
24.62
Price To Sales (TTM)
15.01
Price To Book (MRQ)
13.88
Price To Cash Flow (TTM)
23.90
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
55.02
Return on Equity (TTM)
51.37

Latest News

Latest News

BRIEF-Bioventix Plc Says Bruce Hiscock To Join Board As CFO

* BIOVENTIX PLC - BRUCE HISCOCK WILL JOIN BOARD AS CHIEF FINANCIAL OFFICER WITH IMMEDIATE EFFECT Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up